The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules
- 17 November 2004
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 114 (2) , 154-163
- https://doi.org/10.1016/j.clim.2004.09.001
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Methotrexate markedly reduces the expression of vascular E‐selectin, cutaneous lymphocyte‐associated antigen and the numbers of mononuclear leucocytes in psoriatic skinExperimental Dermatology, 2004
- Modulation of Adhesion Molecule Expression on Endothelial Cells after Induction by Lipopolysaccharide‐Stimulated Whole BloodScandinavian Journal of Immunology, 2004
- Altered tissue expression pattern of cell adhesion molecules, ICAM-1, E-selectin and VCAM-1, in bullous pemphigoid during methotrexate therapyExperimental Dermatology, 2004
- Management of Psoriasis Vulgaris with Methotrexate 0.25% In a Hydrophilic Gel: A Placebo-Controlled, Double-Blind StudyJournal of Cutaneous Medicine and Surgery, 2001
- Circulating levels of soluble E-selectin, ICAM-1 and VCAM-1 in bullous pemphigoid during low-dose methotrexate therapy. A prospective studyExperimental Dermatology, 2000
- Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?Biochemical Journal, 1999
- Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides.Journal of Clinical Investigation, 1998
- Psoriasis: a disease of abnormal Keratinocyte proliferation induced by T lymphocytesImmunology Today, 1986
- Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.Journal of Clinical Investigation, 1983
- Cyclosporin a for PsoriasisNew England Journal of Medicine, 1979